BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 18827884)

  • 1. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
    Cardoso FC; Pacífico RN; Mortara RA; Oliveira SC
    Clin Exp Immunol; 2006 Jun; 144(3):382-91. PubMed ID: 16734606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
    Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
    Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
    Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.
    Alves CC; Araujo N; dos Santos VC; Couto FB; Assis NR; Morais SB; Oliveira SC; Fonseca CT
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003537. PubMed ID: 25723525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
    Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
    Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with adult
    El-Aswad BEW; Harba NM; Moharm IM; Mahmoud SF
    J Helminthol; 2019 Jan; 94():e26. PubMed ID: 30702051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.
    Martins VP; Pinheiro CS; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Azevedo V; Castro-Borges W; Wilson RA; Oliveira SC
    Clin Dev Immunol; 2012; 2012():962538. PubMed ID: 22927873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
    Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
    Front Immunol; 2018; 9():2488. PubMed ID: 30450095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.
    Chalmers IW; Fitzsimmons CM; Brown M; Pierrot C; Jones FM; Wawrzyniak JM; Fernandez-Fuentes N; Tukahebwa EM; Dunne DW; Khalife J; Hoffmann KF
    PLoS Negl Trop Dis; 2015; 9(7):e0003920. PubMed ID: 26147973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
    Pacífico LG; Fonseca CT; Chiari L; Oliveira SC
    Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection.
    Araujo JM; de Melo TT; de Sena IC; Alves CC; Araujo N; Durães Fdo V; Oliveira SC; Fonseca CT
    Acta Trop; 2012 Nov; 124(2):140-6. PubMed ID: 22842304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
    Leow CY; Willis C; Leow CH; Hofmann A; Jones M
    Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats.
    Sepulveda J; Tremblay JM; DeGnore JP; Skelly PJ; Shoemaker CB
    Int J Parasitol; 2010 Oct; 40(12):1407-17. PubMed ID: 20600071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
    Figueiredo BC; Assis NR; Morais SB; Ricci ND; Pinheiro CS; Martins VP; Bicalho RM; Da'dara AA; Skelly PJ; Oliveira SC
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3107. PubMed ID: 25144756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
    Da'Dara AA; Skelly PJ; Walker CM; Harn DA
    Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.